Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-19-001082
Filing Date
2019-08-07
Accepted
2019-08-07 16:02:01
Documents
66
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q usstem20190630_10q.htm 10-Q 964176
2 EXHIBIT 31.1 ex_152622.htm EX-31.1 17198
3 EXHIBIT 32.1 ex_152623.htm EX-32.1 5761
10 chart.jpg GRAPHIC 17325
  Complete submission text file 0001185185-19-001082.txt   5917660

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT usrm-20190630.xml EX-101.INS 1090351
5 XBRL TAXONOMY EXTENSION SCHEMA usrm-20190630.xsd EX-101.SCH 61287
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE usrm-20190630_cal.xml EX-101.CAL 46550
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE usrm-20190630_def.xml EX-101.DEF 322898
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE usrm-20190630_lab.xml EX-101.LAB 543579
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE usrm-20190630_pre.xml EX-101.PRE 326289
Mailing Address 13794 NW 4TH STREET SUITE 212 SUNRISE FL 33325
Business Address 13794 NW 4TH STREET SUITE 212 SUNRISE FL 33325 954-835-1500
U.S. Stem Cell, Inc. (Filer) CIK: 0001388319 (see all company filings)

EIN.: 650945967 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33718 | Film No.: 191005379
SIC: 8731 Services-Commercial Physical & Biological Research